Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Exploiting the power of OMICS approaches to produce E. Coli O157 vaccines
Anjana Kalita
, Mridul Kalita
,
Alfredo G. Torres
Microbiology And Immunology
Research output
:
Contribution to journal
›
Article
›
peer-review
10
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Exploiting the power of OMICS approaches to produce E. Coli O157 vaccines'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Escherichia Coli O157
100%
Enterohemorrhagic Escherichia Coli
100%
Omics Approaches
100%
Vaccine Candidate
75%
O157
50%
Public Health
25%
Protein-protein Interaction
25%
Diarrhea
25%
Immunoinformatics Approach
25%
Th2 Cytokines
25%
Murine Model
25%
Subunit Vaccine
25%
Human Vaccines
25%
Effective Intervention
25%
Very Virulent
25%
Protective Effect
25%
Multifunctional Protein
25%
Causative Agents
25%
Human Pathogens
25%
Gastrointestinal Pathogens
25%
Bioinformatics Tools
25%
Escherichia Coli Strains
25%
Antibiotic Treatment
25%
Gastrointestinal Infection
25%
Sporadic Cases
25%
Recent Infection
25%
In Silico
25%
Multisubunit
25%
Hemorrhagic Colitis
25%
Low Priority
25%
Vaccine Target
25%
STRING Database
25%
Genome-wide Search
25%
Potential Vaccine Candidate
25%
Medicine and Dentistry
Escherichia Coli O157
100%
Enterohemorrhagic Escherichia Coli
100%
Pathogen
50%
Public Health
25%
Diarrhea
25%
Infection
25%
Antibiotic Therapy
25%
Cytokine
25%
Protein Interaction
25%
Escherichia coli
25%
Serotype
25%
Subunit Vaccine
25%
In Silico
25%
Hemorrhagic Colitis
25%
Gastrointestinal Infection
25%
Immunology and Microbiology
Escherichia Coli O157:H7
100%
Enterohemorrhagic Escherichia Coli
100%
Infectious Agent
50%
Infection
50%
Cytokine
25%
Human Pathogen
25%
Subunit Vaccine
25%
Serotype
25%
Escherichia coli
25%
Protein Interaction
25%
Colitis
25%
Bioinformatics
25%
Pharmacology, Toxicology and Pharmaceutical Science
Escherichia Coli O157
100%
Enterohemorrhagic Escherichia Coli
100%
Infectious Agent
50%
Infection
25%
Diarrhea
25%
Subunit Vaccine
25%
Cytokine
25%
Escherichia coli
25%
Hemorrhagic Colitis
25%
Gastrointestinal Infection
25%
Biochemistry, Genetics and Molecular Biology
Enterohemorrhagic Escherichia Coli
100%
Escherichia Coli O157
100%
Infectious Agent
75%
Cytokine
25%
Escherichia coli
25%
Protein Interaction
25%
Serotype
25%
Genomics
25%
Bioinformatics
25%